BNP Paribas Financial Markets’s Vaxart VXRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,542
Closed -$1.15K 5793
2025
Q2
$1.15K Buy
2,542
+66
+3% +$29 ﹤0.01% 5131
2025
Q1
$1.01K Sell
2,476
-211
-8% -$135 ﹤0.01% 5069
2024
Q4
$1.78K Buy
2,687
+211
+9% +$147 ﹤0.01% 5024
2024
Q3
$2.1K Sell
2,476
-159
-6% -$122 ﹤0.01% 3888
2024
Q2
$1.76K Hold
2,635
﹤0.01% 3819
2024
Q1
$3.43K Sell
2,635
-683
-21% -$716 ﹤0.01% 3769
2023
Q4
$1.9K Hold
3,318
﹤0.01% 3811
2023
Q3
$2.5K Buy
3,318
+934
+39% +$710 ﹤0.01% 3705
2023
Q2
$1.74K Sell
2,384
-62,529
-96% -$58.1K ﹤0.01% 3731
2023
Q1
$49.1K Buy
64,913
+50,817
+361% +$47.2K ﹤0.01% 3428
2022
Q4
$13.5K Sell
14,096
-300,287
-96% -$424K ﹤0.01% 3579
2022
Q3
$685K Buy
314,383
+288,740
+1,126% +$996K ﹤0.01% 2756
2022
Q2
$89.8K Buy
25,643
+15,974
+165% +$59.7K ﹤0.01% 3388
2022
Q1
$48.7K Sell
9,669
-16,005
-62% -$81.1K ﹤0.01% 3563
2021
Q4
$161K Buy
25,674
+3,654
+17% +$25K ﹤0.01% 3452
2021
Q3
$175K Buy
22,020
+17,582
+396% +$145K ﹤0.01% 3088
2021
Q2
$33.2K Sell
4,438
-2,945
-40% -$20.6K ﹤0.01% 3399
2021
Q1
$44.7K Buy
7,383
+1,805
+32% +$13.9K ﹤0.01% 3637
2020
Q4
$31.9K Sell
5,578
-6,703
-55% -$42.6K ﹤0.01% 3731
2020
Q3
$81.7K Buy
12,281
+10,613
+636% +$94.5K ﹤0.01% 3225
2020
Q2
$14.8K Buy
+1,668
New +$4.79K ﹤0.01% 3529
2014
Q3
Sell
-6
Closed -$182 4293
2014
Q2
$182 Hold
6
﹤0.01% 3715
2014
Q1
$236 Hold
6
﹤0.01% 3184
2013
Q4
$268 Buy
+6
New +$264 ﹤0.01% 4001

Other funds holding VXRT

BNP Paribas Financial Markets's VXRT Position: Q3 2025 in Review

BNP Paribas Financial Markets sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 2,542 shares — an estimated $1.15K sold.

BNP Paribas Financial Markets first reported a position in VXRT in Q4 2013 and held it in 24 quarters. The position peaked at $685K in Q3 2022. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • BNP Paribas Financial Markets reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 2,542 Vaxart shares in Q3 2025, an estimated $1.15K.
  • BNP Paribas Financial Markets first reported a position in Vaxart in Q4 2013 and held it in 24 quarters.
  • BNP Paribas Financial Markets's Vaxart position peaked at $685K in Q3 2022.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2025, filed 13 Nov 2025.